Effects of recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of 18f-fluorodeoxyglucose and radioiodide

Thyroid

Volumn 21, Issue 7, 2011, Pages 783-792

  Reinfelder, Julia ^a   Maschauer, Simone ^a   Foss, Catherine A ^b   Nimmagadda, Sridhar ^b   Fremont, Valerie ^c   Wolf, Vladimir ^c   Weintraub, Bruce D ^c   Pomper, Martin G ^b   Szkudlinski, Mariusz W ^c   Kuwert, Torsten ^a   Prante, Olaf ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c Trophogen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE THYROTROPIN; CYCLIC AMP; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; HUMAN THYROTROPIN; IODINE 124; IODINE 131; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; SODIUM IODIDE I 124; SODIUM IODIDE I 125; SODIUM IODIDE SYMPORTER; THYROID HORMONE DERIVATIVE; THYROTROPIN; TR 1401; TR 1402; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG UPTAKE; ENDOCRINE FUNCTION TEST; FEMALE; LOW DRUG DOSE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CELL LINE; CYCLIC AMP; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IODINE RADIOISOTOPES; MICE; RATS; RECEPTORS, THYROTROPIN; SODIUM IODIDE; THYROID GLAND; THYROTROPIN; TISSUE DISTRIBUTION;

EID: 79959858680     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2010.0394     Document Type: Article

References (41)

1. Zhu C, Zheng T, Kilfoy BA, Han X, Ma S, Ba Y, Bai Y, Wang R, Zhu Y, Zhang Y 2009A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973- .2004. Thyroid 19:1061-1066.
2. Morris LG, Myssiorek D 2010 Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 200:454-461.
3. Castro MR, Bergert ER, Goellner JR, Hay ID, Morris JC 2001 Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. J Clin Endocrinol Metab 86:5627-5632. (Pubitemid 33070298)
4. Kuwert T, Schmidt D 2010 SPECT/CT in differentiated thyroid carcinoma. Imaging Med 2:235-243.
5. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803. (Pubitemid 43997716)
6. Puxeddu E, Filetti S 2009 The 2009 American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: progress on the road from consensus- to evidence-based practice. Thyroid 19:1145-1147.
7. Arturi F, Russo D, Schlumberger M, du Villard JA, Caillou B, Vigneri P, Wicker R, Chiefari E, Suarez HG, Filetti S 1998 Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab 83:2493-2496. (Pubitemid 28503052)
8. Leboulleux S, Schroeder PR, Busaidy NL, Auperin A, Corone C, Jacene HA, Ewertz ME, Bournaud C, Wahl RL, Sherman SI, Ladenson PW, Schlumberger M 2009 Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer. J Clin Endocrinol Metab 94:1310-1316.
9. Petrich T, Borner AR, Otto D, Hofmann M, Knapp WH 2002 Influence of rhTSH on [18F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging 29:641-647. (Pubitemid 34439324)
10. Weintraub BD, Szkudlinski MW 1999 Development and in vitro characterization of human recombinant thyrotropin. Thyroid 9:447-450. (Pubitemid 29244921)
11. Schroeder PR, Haugen BR, Pacini F, Reiners C, Schlumberger M, Sherman SI, Cooper DS, Schuff KG, Braverman LE, Skarulis MC, Davies TF, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Weintraub BD, Ridgway EC, Ladenson PW 2006A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab 91:878-884. (Pubitemid 43357753)
12. Meier CA, Braverman LE, Ebner SA, Veronikis I, Daniels GH, Ross DS, Deraska DJ, Davies TF, Valentine M, DeGroot LJ 1994 Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab 78:188-196. (Pubitemid 24026771)
13. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD 1997 Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888-896. (Pubitemid 27408571)
14. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon HR, 3rd, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC 1999A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84:3877-3885. (Pubitemid 30644169)
15. Rosario PW, Xavier AC, Calsolari MR 2010 Recombinant human thyrotropin in thyroid remnant ablation with 131- iodine in high-risk patients. Thyroid 20:1247-1252.
16. Szkudlinski MW, Teh NG, Grossmann M, Tropea JE, Weintraub BD 1996 Engineering human glycoprotein hormone superactive analogues. Nat Biotechnol 14:1257-1263. (Pubitemid 26332786)
17. Mueller S, Kleinau G, Jaeschke H, Paschke R, Krause G 2008 Extended hormone binding site of the human thyroid stimulating hormone receptor: distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation. J Biol Chem 283:18048-18055.
18. Szkudlinski MW, Grossmann M, Weintraub BD 1996 Structure-function studies of human TSH New advances in design of glycoprotein hormone analogs. Trends Endocrinol Metab 7:277-286. (Pubitemid 26349557)
19. Grossmann M, Leitolf H, Weintraub BD, Szkudlinski MW 1998A rational design strategy for protein hormone superagonists. Nat Biotechnol 16:871-875. (Pubitemid 28405860)
20. Leitolf H, Tong KP, Grossmann M, Weintraub BD, Szkudlinski MW 2000 Bioengineering of human thyrotropin superactive analogs by site-directed "lysine-scanning" mutagenesis. Cooperative effects between peripheral loops. J Biol Chem 275:27457-27465.
21. Szkudlinski MW, Fremont V, Ronin C, Weintraub BD 2002 Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev 82:473-502. (Pubitemid 34654459)
22. SzkudlinskiMW2004 Recombinant human thyrotropins of the twenty-first century. Expert Opin Pharmacother 5:2435-2440. (Pubitemid 39646506)
23. Mueller S, Kleinau G, Szkudlinski MW, Jaeschke H, Krause G, Paschke R 2009 The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor. J Biol Chem 284:16317-16324.
24. Ruddon RW 1996 Super hormones. Nat Biotechnol 14:1224.
25. Duntas LH, Cooper DS 2008 Review on the occasion of a decade of recombinant human TSH: prospects and novel uses. Thyroid 18:509-516. (Pubitemid 351667835)
26. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22:631-656. (Pubitemid 32955247)
27. Blä ser D, Maschauer S, Kuwert T, Prante O 2006 In vitro studies on the signal transduction of thyroidal uptake of 18FFDG and 131I-Iodide. J Nucl Med 47:1382-1388. (Pubitemid 47544895)
28. Prante O, Blä ser D, Maschauer S, Kuwert T 2007 In vitro characterization of the thyroidal uptake of O-(2-[18F]fluoroethyl)- L-tyrosine. Nucl Med Biol 34:305-314. (Pubitemid 46441857)
29. Meller B, Gaspar E, Deisting W, Czarnocka B, Baehre M, Wenzel BE 2008 Decreased radioiodine uptake of FRTL-5 cells after (131)I incubation in vitro: molecular biological investigations indicate a cell cycle-dependent pathway. Eur J Nucl Med Mol Imaging 35:1204-1212.
30. Ambesi-Impiombato FS, Picone R, Tramontano D 1982 Influence of hormones and serum on growth and differentiation of the thyroid cell strain FRTL. In: Sato GH, Pardee AB, Sirbaku DA (eds) Growth of Cells in Hormonally Defined Media. Vol 9. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 483-492.
31. Prante O, Maschauer S, Fremont V, Reinfelder J, Stoehr R, Szkudlinski M, Weintraub B, Hartmann A, Kuwert T 2009 Regulation of uptake of 18F-FDG by a follicular human thyroid cancer cell line with mutation-activated K-Ras. J Nucl Med 50:1364-1370.
32. Bradford MM 1976A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
33. Kermode JC, Thompson BD, Edmonds CJ 1981 Comparison of binding of bovine and human thyroid-stimulating hormone to receptor sites on human thyroid membranes. J Endocrinol 88:205-217. (Pubitemid 11154376)
34. Calebiro D, Nikolaev VO, Persani L, Lohse MJ 2010 Signaling by internalized G-protein-coupled receptors. Trends Pharmacol Sci 31:221-228.
35. Royaux IE, Suzuki K, Mori A, Katoh R, Everett LA, Kohn LD, Green ED 2000 Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 141:839-845. (Pubitemid 32250509)
36. Kenakin T 2003 Predicting therapeutic value in the lead optimization phase of drug discovery. Nat Rev Drug Discov 2:429-438. (Pubitemid 37361724)
37. Hou P, Bojdani E, Xing M 2010 Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways. J Clin Endocrinol Metab 95:820-828.
38. Matsumoto H, Sakamoto A, Fujiwara M, Yano Y, Shishido- Hara Y, Fujioka Y, Kamma H 2008 Decreased expression of the thyroid-stimulating hormone receptor in poorly-differentiated carcinoma of the thyroid. Oncol Rep 19:1405-1411.
39. Baenziger JU, Green ED 1988 Pituitary glycoprotein hormone oligosaccharides: structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin. Biochim Biophys Acta 947:287-306.
40. Szkudlinski MW, Thotakura NR, Bucci I, Joshi LR, Tsai A, East-Palmer J, Shiloach J, Weintraub BD 1993 Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity. Endocrinology 133:1490-1503. (Pubitemid 23295171)
41. Bucci I, Szkudlinski MW, Thotakura NR, Monaco F, Weintraub BD 1994 The role of sulfation in the organ distribution, clearance and bioactivity of bovine and rat TSH. J Endocrinol Invest 17:86.